David Gionco, Chief Accounting Officer at STEMLINE THERAPEUTICS INC (STML), sold 8,500 shares at $13.43 ($114K) on 2018-01-17, disclosed to the SEC on 2018-01-19.
Seasonal sale ($114k) by Chief Accounting Officer — this insider has traded STML in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.43 | 4,250 | $57K | 50.0% |
| 2 | $13.43 | 4,250 | $57K | 50.0% |
| Total | $13.43 avg | 8,500 | $114K | 100% |
| Filing → |
| STML | SELL | 2020-03-13 | $69K | — | Filing → |
| STML | SELL | 2020-02-28 | $118K | — | Filing → |
| STML | SELL | 2020-01-03 | $49K | — | Filing → |